NL-OMON23346招募中不适用
High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy.
EBMT/EULAR Working Party Autoimmune Diseases.0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
van Laar JM, Farge D, Tyndall A, on behalf of the EBMT/EULAR Scleroderma Study Group. Stem cell transplantation in systemic sclerosis: hope on the horizon. Ann Rheum Dis 2005, in press.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with diffuse systemic sclerosis, aged 16-65 yrs, and:
- •1. Disease duration 4 years or less, plus evidence of heart, lung or kidney involvement, plus skin score 15 or more, or:
排除标准
- •Patients with concomitant severe disease, extensive pretreatment according to predefined criteria with cyclophosphamide are excluded.
研究者
相似试验
进行中(未招募)
不适用
High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy cyclophosphamide in severe systemic sclerosis ( ‘ASTIS’-TRIAL: Autologous Stem Cell Transplantation International Scleroderma Trial) - ASTISSevere systemic sclerosisMedDRA version: 9.1Level: LLTClassification code 10042953Term: Systemic sclerosisEUCTR2006-004598-83-GBEBMT (European group for Blood and Marrow Transplantation)150
已完成
不适用
Autologous Stem cell Transplantation International Scleroderma (ASTIS) trialSystemic sclerosisMusculoskeletal DiseasesISRCTN54371254European Group for Bone Marrow Transplantation156
终止
2 期
Cardiac Safe Transplants for Systemic SclerosisSclerodermaSystemic SclerosisNCT03593902Northwestern University9
已完成
2 期
Collection of Transplant Stem Cells for Plasma Cell MyelomaPlasma Cell MyelomaMultiple MyelomaNCT01547806National Cancer Institute (NCI)49
进行中(未招募)
1 期
Stem cell transplantation in diffuse cutaneous systemic sclerosis: upfront therapy or rescue therapy after failure of immunosuppressantsDiffuse cutaneous systemic sclerosis according to the ACR/EULAR criteriaMedDRA version: 20.0Level: SOCClassification code: 10021428Term: Immune system disorders Class: 4CTIS2023-505877-34-00niversity Medical Center Utrecht88
